Envoy Medical (COCH) Stock Price, News & Analysis

Company Overview

Envoy Medical (NASDAQ:COCH) is a medical device company focused on non-invasive neuromodulation therapies for dysphagia, a swallowing disorder that affects patients following neurological events or due to degenerative conditions. The company’s lead technology delivers targeted electrical stimulation designed to strengthen the muscles and neural pathways involved in the swallowing process.

Envoy Medical’s flagship therapy has received regulatory clearance from the U.S. Food and Drug Administration and is being introduced through rehabilitation centers, speech-language pathology clinics and acute care hospitals. The company works closely with healthcare providers to integrate its device into patient care pathways, supporting therapy both in clinical environments and at home.

Headquartered in the Minneapolis–Saint Paul metropolitan area, Envoy Medical currently serves the U.S. market and is evaluating opportunities for expansion into select international regions. Its leadership team combines expertise in medical device development, rehabilitation sciences and commercial operations, backed by private financing aimed at advancing innovative therapies for neurological and musculoskeletal disorders.

Key Stats

• Today's Range: $1.24 to $1.32
• 50-Day Range: $1.12 to $1.70
• 52-Week Range: $1.06 to $3.99
• Volume: 58,771 shs
• Average Volume: 112,092 shs
• Market Capitalization: $27.44 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: $9.25
• Consensus Rating: Buy

Envoy Medical Stock Analysis - MarketRank™

Envoy Medical scored higher than 32% of companies evaluated by MarketBeat, and ranked 771st out of 923 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 3.5 / 5
• Analyst Rating: Buy

Consensus Rating

Envoy Medical has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 2 buy ratings, no hold ratings, and no sell ratings.

Upside Potential

Envoy Medical has a consensus price target of $9.25, representing about 625.5% upside from its current price of $1.28.

Amount of Analyst Coverage

Envoy Medical has received no research coverage in the past 90 days.

Earnings and Valuation

• Score: 0.0 / 5
• Proj. Earnings Growth: Decreasing

Earnings Growth

Earnings for Envoy Medical are expected to decrease in the coming year, from ($1.21) to ($1.23) per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Envoy Medical is -0.89, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of Envoy Medical is -0.89, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Short Interest

• Score: 3.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

0.92% of the float of Envoy Medical has been sold short.

Short Interest Ratio / Days to Cover

Envoy Medical has a short interest ratio ("days to cover") of 0.4, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Envoy Medical has recently increased by 1.63%, indicating that investor sentiment is decreasing.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Envoy Medical does not currently pay a dividend.

Dividend Growth

Envoy Medical does not have a long track record of dividend growth.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Percentage of Shares Shorted

0.92% of the float of Envoy Medical has been sold short.

Short Interest Ratio / Days to Cover

Envoy Medical has a short interest ratio ("days to cover") of 0.4, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Envoy Medical has recently increased by 1.63%, indicating that investor sentiment is decreasing.

News and Social Media

• Score: 0.6 / 5
• News Sentiment: N/A

Search Interest

Only 1 people have searched for COCH on MarketBeat in the last 30 days. This is a decrease of 0% compared to the previous 30 days.

MarketBeat Follows

1 people have added Envoy Medical to their MarketBeat watchlist in the last 30 days.

Company Ownership

• Score: 1.7 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Envoy Medical insiders have not sold or bought any company stock.

Percentage Held by Insiders

58.90% of the stock of Envoy Medical is held by insiders. A high percentage of insider ownership can be a sign of company health.

Percentage Held by Institutions

Only 8.59% of the stock of Envoy Medical is held by institutions.

COCH Stock Analysis - Frequently Asked Questions

How have COCH shares performed this year?

Envoy Medical's stock was trading at $1.43 on January 1st, 2025. Since then, COCH shares have decreased by 10.8% and is now trading at $1.2750.

How were Envoy Medical's earnings last quarter?

Envoy Medical, Inc. (NASDAQ:COCH) posted its earnings results on Thursday, July, 31st. The company reported ($0.32) EPS for the quarter, missing the consensus estimate of ($0.29) by $0.03. The firm earned $0.08 million during the quarter, compared to the consensus estimate of $0.07 million.

Who are Envoy Medical's major shareholders?

Envoy Medical's top institutional investors include NorthRock Partners LLC (48.25%). Insiders that own company stock include Brent T Lucas, Charles Brynelsen and Mona Chetan Patel.
View institutional ownership trends.

How do I buy shares of Envoy Medical?

Shares of COCH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Envoy Medical own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Envoy Medical investors own include Avino Silver & Gold Mines (ASM), Tesla (TSLA), XPeng (XPEV), AbCellera Biologics (ABCL), AutoZone (AZO), CrowdStrike (CRWD) and JPMorgan Chase & Co. (JPM).

Company Calendar

• Last Earnings: 7/31/2025
• Today: 9/10/2025
• Next Earnings (Estimated): 11/13/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: MED INSTRUMENTS
• Sub-Industry: Medical Equipment
• Current Symbol: NASDAQ:COCH
• CIK: 1840877
• Web: www.envoymedical.com
• Phone: 877-900-3277
• Fax: N/A
• Employees: 34
• Year Founded: N/A

Price Target and Rating

• Average Price Target for Envoy Medical: $9.25
• High Price Target: $9.50
• Low Price Target: $9.00
• Potential Upside/Downside: +640.0%
• Consensus Rating: Buy
• Rating Score (0-4): 3.00
• Research Coverage: 2 Analysts

Profitability

• EPS (Trailing Twelve Months): ($1.43)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$20.80 million
• Net Margins: -10,961.26%
• Pretax Margin: -9,579.28%
• Return on Equity: N/A
• Return on Assets: -236.14%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 0.94
• Quick Ratio: 0.74

Sales & Book Value

• Annual Sales: $222 thousand
• Price / Sales: 121.18
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: ($0.88) per share
• Price / Book: -1.42

Miscellaneous

• Outstanding Shares: 21,521,000
• Free Float: 8,845,000
• Market Cap: $26.90 million
• Optionable: Not Optionable
• Beta: 2.20